Back to search

Article

Rivaroxaban in patients with abdominal aortic aneurysm and high-sensitivity C-reactive protein elevation (BANBOO): study protocol for a randomized, controlled trial

2022-11-15

Abstract excerpt

<title>Abstract</title><p><bold>Background</bold>Abdominal aortic aneurysm (AAA) is a fatal disease due to the propensity to rupture. The drug treatment for small AAA without surgical indications has been controversial. Previous studies showed that high-sensitivity C-reactive protein (hs-CRP) had become a potential biomarker of the disease, and the anti-inflammatory effect of rivaroxaban for AAA has been corrobora...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5667372b-6d35-5b45-bfb4-ac1a7b23982f
DOI
10.21203/rs.3.rs-2200813/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Rivaroxaban in patients with abdominal aortic aneurysm and high-sensitivity C-reactive protein elevation (BANBOO): study protocol for a randomized, controlled trialDOI 10.21203/rs.3.rs-2200813/v1
Select a neighboring publication to make it the new centre.